Molecular imaging of tumor invasion and metastases: the role of MRI

No abstract is available for this paper.

• Publication year

  2010

• Venue

  NMR in Biomedicine

• Publication date

  2010-12-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/nbm.1590PMID 21793070PMCID PMC3432422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radiofluorinated Pyrimidine‐2,4,6‐triones as Molecular Probes for Noninvasive MMP‐Targeted Imaging

  2010cited by this paper
• Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity.

  2010cited by this paper
• Molecular Imaging

  2009cited by this paper
• Molecular imaging in clinical trials

  2009cited by this paper
• Optical proteolytic beacons for in vivo detection of matrix metalloproteinase activity.

  2009cited by this paper
• Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides.

  2009cited by this paper
• In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer.

  2009cited by this paper
• Protease-specific nanosensors for magnetic resonance imaging.

  2008cited by this paper
• Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer.

  2008cited by this paper
• Integrins in angiogenesis and lymphangiogenesis

  2008cited by this paper
• Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT

  2007cited by this paper
• Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.

  2007cited by this paper
• Preparation of Biocompatible Magnetite Nanocrystals for In Vivo Magnetic Resonance Detection of Cancer

  2006cited by this paper
• Matrix metalloproteinases and tumor metastasis

  2006influential reference
• Cysteine cathepsins: multifunctional enzymes in cancer

  2006cited by this paper
• Fast Whole-Body Assessment of Metastatic Disease Using a Novel Magnetic Resonance Imaging System: Initial Experiences

  2005cited by this paper
• High-Resolution Whole-Body Magnetic Resonance Image Tumor Staging With the Use of Parallel Imaging Versus Dual-Modality Positron Emission Tomography–Computed Tomography: Experience on a 32-Channel System

  2005cited by this paper
• Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle.

  2005cited by this paper
• Dendrimers in biomedical applications--reflections on the field.

  2005cited by this paper
• A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation.

  2005cited by this paper
• Superparamagnetic Iron Oxide Nanoparticles: Nodal Metastases and Beyond

  2004cited by this paper
• Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo.

  2004cited by this paper
• Tumor imaging by means of proteolytic activation of cell-penetrating peptides.

  2004cited by this paper
• Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent.

  2004cited by this paper
• New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents.

  2004cited by this paper
• Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer

  2004cited by this paper
• Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue

  2004cited by this paper
• Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent.

  2003cited by this paper
• Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor.

  2003cited by this paper
• Dendrimer-based Macromolecular MRI Contrast Agents: Characteristics and Application

  2003cited by this paper
• Prevalence and Patterns of Bone Metastases Detected with Positron Emission Tomography Using F-18 FDG

  2003cited by this paper
• Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.

  2003cited by this paper
• Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging

  2002cited by this paper
• Molecular imaging.

  2001cited by this paper
• In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection.

  2001cited by this paper
• Synthesis and characterization of 111In-DTPA-N-TIMP-2: a radiopharmaceutical for imaging matrix metalloproteinase expression.

  2001cited by this paper
• Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: Comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core

  2001cited by this paper
• In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection

  2001cited by this paper
• Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.

  2000cited by this paper
• In vivo imaging of proteolytic enzyme activity using a novel molecular reporter.

  2000cited by this paper
• Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system.

  1999cited by this paper
• In vivo imaging of tumors with protease-activated near-infrared fluorescent probes

  1999cited by this paper
• The sentinel node in breast cancer--a multicenter validation study.

  1998cited by this paper
• Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review.

  1996cited by this paper
• Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.

  1996cited by this paper
• The war on cancer.

  1996cited by this paper
• Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.

  1996cited by this paper
• The war on cancer.

  1996cited by this paper
• Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.

  1994cited by this paper
• Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer.

  1994cited by this paper
• Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.

  1990cited by this paper
• Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.

  1990cited by this paper
• Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging.

  1988cited by this paper
• Distribution pattern of metastatic bone disease. A need for total body skeletal image.

  1977cited by this paper
• An approach for the treatment of penile carcinoma

  1977cited by this paper

• Imaging diagnosis of metastatic breast cancer

  2020cites this paper
• Cancer Molecular and Functional Imaging

  2020cites this paper
• Folic acid-cysteamine modified gold nanoparticle as a nanoprobe for targeted computed tomography imaging of cancer cells.

  2018cites this paper
• Current status and future challenges for molecular imaging

  2017cites this paper
• Tetrapyrrole-based theranostic combinations of photodynamic action and magnetic resonance imaging

  2017cites this paper
• 99mTc-labeled and gadolinium-chelated transferrin enhances the sensitivity and specificity of dual-modality SPECT/MR imaging of breast cancer

  2016cites this paper
• MR molecular imaging of tumors based on an optimal hTERT promoter tyrosinase expression system

  2016cites this paper
• Biomarkers and their Role in Premonition, Elucidation and Treatment of Cancer

  2015cites this paper
• The development, use, and optimization of sortase-tag expressed protein ligation

  2015cites this paper
• Integrative analysis of cancer imaging readouts by networks

  2014cites this paper
• Frontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinoma.

  2014cites this paper
• Non-invasive optical imaging of cathepsin B with activatable fluorogenic nanoprobes in various metastatic models.

  2014cites this paper
• Molecular Imaging Probes: Activatable and Sensing Probes

  2014cites this paper
• Synthesis of nanomaterials for biomedical applications

  2014cites this paper
• Synthesis and Radiopharmacological Characterisation of a Fluorine‐18‐Labelled Azadipeptide Nitrile as a Potential PET Tracer for in vivo Imaging of Cysteine Cathepsins

  2013cites this paper
• New whole-body multimodality imaging of gastric cancer peritoneal metastasis combining fluorescence imaging with ICG-labeled antibody and MRI in mice

  2013cites this paper
• Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma.

  2013cites this paper
• Galactosylated manganese ferrite nanoparticles for targeted MR imaging of asialoglycoprotein receptor

  2013cites this paper
• Development of Magnetic Nanoparticles for Cancer Gene Therapy: A Comprehensive Review

  2013cites this paper
• One-to-one laccase–gold nanoparticle conjugates: molecular recognition and activity enhancement

  2013cites this paper
• Unique Diagnostic and Therapeutic Roles of Porphyrins and Phthalocyanines in Photodynamic Therapy, Imaging and Theranostics

  2012cites this paper
• Anchored proteinase-targetable optomagnetic nanoprobes for molecular imaging of invasive cancer cells.

  2012cites this paper
• MR evaluation of response to targeted treatment in cancer cells

  2011influential citation
• Unravelling the complexity of metastasis — molecular understanding and targeted therapies

  2011cites this paper
• Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals.

  2011cites this paper
• Biomarkers and their Role in Premonition, Interpretation and Treatment of Cancer

  2011cites this paper